The symptom mitigation path of mobile community residents: Community pharmacy's role

Health Policy

Volumn 89, Issue 1, 2009, Pages 14-25

  Väänänen, Minna Heleena ^a   Lyles, Alan ^b   Airaksinen, Marja ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF BALTIMORE   (United States)

Author keywords

Mobile patients; Pharmaceutical policy; Qualitative study; Role of community pharmacy

Indexed keywords

ARTICLE; HEALTH CARE ACCESS; HEALTH SERVICE; MEDICAL PRACTICE; PATIENT COUNSELING; PATIENT INFORMATION; PHARMACY; PRESCRIPTION; SPAIN;

AGED; AGED, 80 AND OVER; COMMUNITY PHARMACY SERVICES; EUROPE; FEMALE; FINLAND; FOCUS GROUPS; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; MALE; MIDDLE AGED; POLICY MAKING; ROLE; SPAIN; TRAVEL;

EID: 57149101159     PISSN: 01688510     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healthpol.2008.04.011     Document Type: Article

References (53)

1. European Commission. The EU single market. Available at: http://ec.europa.eu/internal_market/index_en.htm (April 20, 2007).
2. Ortega Perez N. Spain: forging an immigration policy. Migration Policy Institute, 2003. Available at: http://www.migrationinformation.org/Profiles/display.cfm?ID=97 (November 20, 2007).
3. Hardill I, Spradberry J, Arnold-Boakes J, Marrugat ML. Retirement migration: the other story. Issues facing English speaking migrants who retire to Spain. RSA Conference. Europe at the Margins: EU regional policy, peripherality and rurality. April 4, 2004.
4. Casado-Diaz M.A., Kaiser C., and Warnes A.M. Northern European retired residents in nine southern European areas: characteristics, motivations and adjustment. Ageing and Society 24 (2004) 353-381
5. WHO. The European Health Report. WHO Europe, 2002. Available at: http://www.euro.who.int/document/e76907.pdf (October 22, 2007).
6. European Commission. High-level reflection process on patient mobility and healthcare developments in the European Union. Brussels, European Commission, 2003. Available at: http://www.iese.edu/en/events/Projects/Health/RelatedDocuments/European_Union/EuropeanUnion-PatientMobility.asp (October 22, 2007).
7. European Commission. Communication from the Commission: follow-up the high-level reflection process on patient mobility and healthcare developments in the European Union. Brussels, European Commission, 2004. Available at: http://www.iese.edu/en/events/Projects/Health/RelatedDocuments/European_Union/EuropeanUnion-PatientMobility.asp (October 22, 2007).
8. European Commission. High-level process of reflection on patient mobility and healthcare developments in the European Union: outcome of the reflection process. Brussels, European Commission, 2004. Available at: http://www.iese.edu/en/events/Projects/Health/RelatedDocuments/European_Union/EuropeanUnion-PatientMobility.asp (October 22, 2007).
9. Väänänen M.H., Pietilä K., and Airaksinen M. Immigration within European Union-does health immigration make a difference in analgesic use?. Pharmacy Practice 4 4 (2006) 156-162
10. Bradley C, Holme Hansen E, Kooiker S. Patients and their medicines. in: Mossialos E, Mrazek M, Walley T, editors. Regulating pharmaceuticals in Europe: striving for efficiency, equity and quality. Open University Press; 2004. p. 160-161. Available at: http://www.euro.who.int/observatory/Publications/20040527_2 (July 20, 2006).
11. Hassell K., Noyce P.R., Rogers A., Harris J., and Wilkinson J. A pathway to the GP: the pharmaceutical 'consultation' as a first port of call in primary health care. Family Practice 14 6 (1997) 498-502
12. Norgaard L.S., Colberg L., and Nieman M.R. The role of the Danish community pharmacist: perceptions and future scenarios. Pharmacy World and Science 23 4 (2001) 159-164
13. Iversen L., Mollison J., and MacLeod N.N. Attitudes of the general public to the expanding role of community pharmacists: a pilot study. Family Practice 18 5 (2001) 534-536
14. Olsson E., Tuyet L.T.N., and Lundborg S.C. Health professionals' and consumers' views on the role of the pharmacy personnel and pharmacy service in Hanoi, Vietnam-a qualitative study. Journal of Clinical Pharmacy and Therapeutics 27 (2002) 273-280
15. Bislew H.D., and Sorensen T.D. Use of focus groups as a tool to enhance a pharmaceutical care practice. Journal of the American Pharmaceutical Association 43 3 (2003) 424-433
16. Bojke C., Gravelle H., Hassell K., and Whittington Z. Increasing patient choice in primary care: the management of minor ailments. Health Economics 13 (2004) 73-86
17. Helper C.D., and Strand L. Opportunities and responsibilities in pharmaceutical care. American Journal of Hospital Pharmacy 47 (1990) 533-543
18. Farris K.B., Fernandez-Llimos F., and Benrimoj C.S.I. Pharmaceutical care in community pharmacies: practice and research around the World. The Annals of Pharmacotherapy 39 (2005) 1539-1541
19. Roughead L, Semple S, Vitry A. The value of pharmacist professional services in the community setting. The pharmacy quild of Australia, 2005 Available at: http://beta.guild.org.au/uploadedfiles/Research_and_Development_Grants_Program/Projects/2002-507_fr.pdf (December 12, 2006).
20. Eickhoff C., and Schulz M. Pharmaceutical care in community pharmacies: practice and research in Germany. The Annals of Pharmacotherapy 40 (2006) 729-735
21. Westerlund T.L.O., and Björk T.H. Pharmaceutical care in community pharmacies: practice and research in Sweden. The Annals of Pharmacotherapy 40 (2006) 1162-1169
22. Van Mil F.J.W. Pharmaceutical care in community pharmacy: practice and research in The Netherlands. The Annals of Pharmacotherapy 39 (2005) 1720-1725
23. Bell S., Väänänen M., Ovaskainen H., Närhi U., and Airaksinen M. Providing patient care in community pharmacies: practice and research in Finland. The Annals of Pharmacotherapy 41 6 (2007) 1039-1046
24. Pharmaceutical Forum, Information to Patients Working Group. Patients' access to information in community pharmacies. Draft Summary Report: PGEU/EATG Workshop, Brussels, November 7, 2006. Available at: http://ec.europa.eu/enterprise/phabiocom/docs/pf_rel_doc1.pdf (November 1, 2007).
25. Anderson C., Blenkinsopp A., and Armstrong M. Feedback from community pharmacy users on the contribution of community pharmacy to improving the public's health: a systematic review of the peer reviewed and non-peer reviewed literature 1990-2002. Health Expectations 7 3 (2004) 191-202
26. Behind the Counter Availability of Certain Drugs; Public Meeting. Fed Regist 2007; 72 (192):56769. Available at: http://a257.g.akamaitech.net/7/257/2422/01jan20071800/edocket.access.gpo.gov/2007/pdf/E7-19576.pdf (November 1, 2007).
27. Lyles A. The prescribing continuum: between prescription and over-the-counter drugs (Editorial). Clinical Therapeutics 29 10 (2007) 2244-2245
28. Hibbert D., Bissell P., and Ward P.R. Consumerism and professional work in community pharmacy. Sociology of Health and Illness 24 1 (2002) 45-65
29. Van der Geest S. Self-care and the informal sale of drugs in South Cameroon. Social Science and Medicine 25 3 (1987) 293-305
30. Price L.J. In the shadow of biomedicine: self-medication in two Ecuadorian pharmacies. Social Science and Medicine 28 9 (1989) 905-915
31. Hardon A.P. The use of modern pharmaceuticals in a Filipino village: doctors prescription and self-medication. Social Science and Medicine 25 3 (1987) 277-292
32. Greenhalhg T. Drug prescription and self-medication in India: an exploratory survey. Social Science and Medicine 25 3 (1987) 307-318
33. DeNavas-Walt C, Proctor BD, and Smith J.U.S. Census Bureau. Table 6. People With or Without Health Insurance Coverage by Selected Characteristics: 2005 and 2006. Current Population Reports, P60-233, Income, Poverty, and Health Insurance Coverage in the United States: 2006. U.S. Government Printing Office; Washington, DC, 2007.
34. Smith F. Research methods in pharmacy practice. 1st ed. (2002), The Pharmaceutical Press, London
35. Silverman D. Doing qualitative research. A practical handbook (2000), Sage, London
36. Larsen B.O., and Hansen E.H. The active medicine user. Scandinavian Journal of Primary Health Care 3 1 (1985) 55-59
37. Sihvo S. Utilization and appropriateness of self-medication in Finland. Stakes research report 111. Doctoral Thesis. University of Helsinki, 2000.
38. Leemans L., Veroeveren L., Bulens J., Hendrickx C., Keynberg W., Niesten F., et al. Frequency and trends of interventions of prescriptions in Flemish community pharmacies. Pharmacy World and Science 25 2 (2003) 65-69
39. Chamba G., Bauguil G., and Gallezot J. The role of the French community pharmacist in drug dispensing. Pharmacy World and Science 21 3 (1999) 142-143
40. Westerlund T., Almarsdottir A.B., and Melander A. Drug-related problems and pharmacy interventions in community practice. International Journal of Pharmacy Practice 7 (1999) 40-50
41. Närhi U., Airaksinen M., Tanskanen P., and Enlund H. Therapeutic outcomes monitoring by community pharmacists for improving clinical outcomes in asthma. Journal of Clinical Pharmacy and Therapeutics 25 (2000) 177-183
42. Närhi U., Airaksinen M., Tanskanen P., and Enlund H. The effects of a pharmacy-based intervention on the knowledge and attitudes of asthma patients. Patient Education and Council 43 (2001) 171-177
43. Tully M.P., and Seston E.M. Impact of pharmacists providing a prescription review and monitoring service in ambulatory care or community practice. The Annals of Pharmacotherapy 34 (2000) 1320-1331
44. Schulz M., Verheyen F., Muhlig S., Muller J.M., Muhlbauer K., Knoå-Schneickert E., et al. Pharmaceutical care services for asthma patients: a controlled intervention study. Journal of Clinical Pharmacology 41 (2001) 668-676
45. Fornos J.A., Andres N.F., Andres J.C., Guerra M.M., and Egea B. A pharmacotherapy follow-up program in patients with type-2 diabetes in community pharmacies in Spain. Pharmacy World and Science 28 (2006) 65-72
46. Mangiapane S., Schulz M., Muhlig S., Schubert I., and Waldmann H.-C. Community pharmacy-based pharmaceutical care for asthma patients. The Annals of Pharmacotherapy 39 (2005) 1817-1822
47. Paulos C.P., Akesson Nygren E.A., Celedon C., and Carmaco C.A. Impact of a pharmaceutical care program in a community pharmacy on patients with dyslipidemia. The Annals of Pharmacotherapy 39 (2005) 939-943
48. FIP: Statement of professional standards: Code of ethics for pharmacists. Available at: http://213.206.88.26/www2/uploads/database_file.php?id=209&table_id= (4 July 2006).
49. Väänänen M.H., Pietilä K., and Airaksinen M. Self-medication with antibiotics-does it really happen in Europe. Health Policy 77 (2006) 166-171
50. Barbero-Gonzalez A., Pastor-Sanchez R., del Arco-Ortiz de Zarate J., Eyaralar-Riera T., and Espejo-Guerrero J. Demand for dispensing of medicines without medical prescription. Atencion Primaria 37 2 (2006) 78-87
51. Caamano Isorna F., Tome-Otero M., Takkouche B., and Figueiras A. Factors related with prescription requirement to dispense in Spain. Pharmacoepidemiology and Drug Safety 13 6 (2004) 405-409
52. Figueiras A., Caamano F., and Gestal-Otero J.J. Sociodemographic factors related to self-medication in Spain. European Journal of Epidemiology 16 (2000) 19-26
53. Scrip: fines for Spanish pharmacists dispensing prescription drugs without scripts. Scrip 2005; 3107.